लोड हो रहा है...
Relapsed and refractory primary CNS lymphoma: treatment approaches in routine practice
Despite recent therapeutic progress and improved survival for many patients with primary central nervous system lymphoma (PCNSL), up to 50% of patients will experience refractory or relapsed disease following first-line treatment with high dose methotrexate (HD-MTX) based regimens. The majority of s...
में बचाया:
| में प्रकाशित: | Ann Lymphoma |
|---|---|
| मुख्य लेखकों: | , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
2021
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7612457/ https://ncbi.nlm.nih.gov/pubmed/35253010 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/aol-21-20 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|